Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly
Rajan Rolta, Rohitash Yadav, Deeksha Salaria, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 18, pp. 7017-7034
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 140
Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
Rajan Rolta, Deeksha Salaria, PremPrakash Sharma, et al.
Current Pharmacology Reports (2021) Vol. 7, Iss. 4, pp. 135-149
Open Access | Times Cited: 83
Tartary Buckwheat in Human Nutrition
Zlata Luthar, Aleksandra Golob, Mateja Germ, et al.
Plants (2021) Vol. 10, Iss. 4, pp. 700-700
Open Access | Times Cited: 79
In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
Mithun Rudrapal, Abdul Rashid Issahaku, Clement Agoni, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10437-10453
Closed Access | Times Cited: 65
Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
Mithun Rudrapal, Neelutpal Gogoi, Dipak Chetia, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 4, pp. 2432-2446
Open Access | Times Cited: 63
Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles
Binod Kumar, Grant M. Hawkins, Tom Kicmal, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 853-853
Open Access | Times Cited: 57
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components
Devvret Verma, Debasis Mitra, Manish Paul, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100038-100038
Open Access | Times Cited: 52
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
Rohitash Yadav, Shazia Hasan, Sumit Kumar Mahato, et al.
Journal of Molecular Liquids (2021) Vol. 342, pp. 116942-116942
Open Access | Times Cited: 46
Antibacterial Potential of Bacopa monnieri (L.) Wettst. and Its Bioactive Molecules against Uropathogens—An In Silico Study to Identify Potential Lead Molecule(s) for the Development of New Drugs to Treat Urinary Tract Infections
Jyoti Mehta, Kumar Utkarsh, Shivkanya Fuloria, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4971-4971
Open Access | Times Cited: 33
Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
Jyoti Mehta, Rajan Rolta, Brij Bhushan Mehta, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 28
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches
Swagatika Dash, Ekta Rathi, Avinash Kumar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Breeding Buckwheat for Increased Levels of Rutin, Quercetin and Other Bioactive Compounds with Potential Antiviral Effects
Zlata Luthar, Mateja Germ, Matevž Likar, et al.
Plants (2020) Vol. 9, Iss. 12, pp. 1638-1638
Open Access | Times Cited: 44
Antiviral activity of bioactive phytocompounds against coronavirus: An update
Riya Bhattacharya, Kamal Dev, Anuradha Sourirajan
Journal of Virological Methods (2021) Vol. 290, pp. 114070-114070
Open Access | Times Cited: 37
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity
Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2949-2949
Open Access | Times Cited: 36
Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
Tatsuhito Matsuo
Biology (2021) Vol. 10, Iss. 6, pp. 454-454
Open Access | Times Cited: 33
An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer
Baljinder Kaur, Rajan Rolta, Deeksha Salaria, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4077-4077
Open Access | Times Cited: 26
Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach
Deeksha Salaria, Rajan Rolta, Jyoti Mehta, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265420-e0265420
Open Access | Times Cited: 23
Promising Role of Emodin as Therapeutics to Against Viral Infections
Qingqing Shao, Tong Liu, Wenjia Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
Rajan Rolta, Deeksha Salaria, Bhanu Sharma, et al.
Current Pharmacology Reports (2022) Vol. 8, Iss. 2, pp. 149-170
Open Access | Times Cited: 22
AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus
Chirag Patel, Raghvendra Mall, Halima Bensmail
Journal of Infection and Public Health (2023) Vol. 16, Iss. 5, pp. 799-807
Open Access | Times Cited: 15
Bioprospecting phytochemicals of Rosmarinus officinalis L. for targeting SARS-CoV-2 main protease (Mpro): a computational study
Unnati P. Patel, Krishna Desai, Ranjitsinh C. Dabhi, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 5
Open Access | Times Cited: 13
Identification of novel inhibitor phytoconstituents for Influenza A H3N2: an in silico approach
Rajan Rolta, Deeksha Salaria, Olatomide A. Fadare, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-10
Closed Access | Times Cited: 4
In silico elucidation for the identification of potential phytochemical against ACE-II inhibitors
Ekambaram Gayathiri, Palanisamy Prakash, Kuppusamy Selvam, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 3
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top